Bevenopran
CAS No. 676500-67-7
Bevenopran( CB-5945 | ADL-5945 )
Catalog No. M26628 CAS No. 676500-67-7
Bevenopran is a peripheral antagonist of μ-opioid receptor and can be used in studies about the treatment of opioid-induced bowel dysfunction.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 349 | Get Quote |
|
| 10MG | 519 | Get Quote |
|
| 25MG | 833 | Get Quote |
|
| 50MG | 1134 | Get Quote |
|
| 100MG | 1512 | Get Quote |
|
| 500MG | 3042 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBevenopran
-
NoteResearch use only, not for human use.
-
Brief DescriptionBevenopran is a peripheral antagonist of μ-opioid receptor and can be used in studies about the treatment of opioid-induced bowel dysfunction.
-
DescriptionBevenopran is a peripheral antagonist of μ-opioid receptor and can be used in studies about the treatment of opioid-induced bowel dysfunction.(In Vivo):Bevenopran tends to increase bowel movement (BM) frequency, especially for 0.1 mg twice daily and 4 mg daily, respectively.
-
In Vitro——
-
In VivoBevenopran is a peripheral μ-opioid receptor antagonist. Bevenopran is currently under investigation for the treatment of opioid-induced bowel dysfunction (OBD). Bevenopran tends to increase bowel movement (BM) frequency, especially for 0.1 mg twice daily and 4 mg daily, respectively.
-
SynonymsCB-5945 | ADL-5945
-
PathwayEndocrinology/Hormones
-
TargetOpioid Receptor
-
RecptorAcidic mammalian chitinase (AMCase)| Chitotriosidase (CHIT1)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number676500-67-7
-
Formula Weight386.452
-
Molecular FormulaC20H26N4O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (323.47 mM)
-
SMILESCOc1cc(CNCCC2CCOCC2)ccc1Oc1cnc(cn1)C(N)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Robert Koralewski, et al. Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis. J Med Chem. 2020 Dec 24;63(24):15527-15540.
molnova catalog
related products
-
DuP 747 HCl
DuP 747 HCl is a selective kappa agonist with analgesic activity.DuP 747 consists of two conformations.
-
BRL 52537 hydrochlor...
BRL 52537 hydrochloride is a selective and specific KOR agonist which has been implicated in neuroprotection from ischemic neuronal injury.
-
Calenduloside E
Calenduloside E exhibits hypoglycemic activities by suppressing the transfer of glucose from the stomach to the small intestine and by inhibiting glucose transport at the brush border of the small intestine in oral glucose-loaded rats.
Cart
sales@molnova.com